金融界5月6日消息,有投资者在互动平台向博腾股份提问:董秘你好,公司有合成尼古丁原料的技术吗,谢谢。
公司回答表示:公司于 2014 年获得欧洲药品质量管理和医疗保健局(EDQM) 签发的尼古丁原料药 CEP 证书,用于药用尼古丁领域,后续又获得电子烟用烟碱牌照。公司将在技术能力、供应链能力和市场开发层面,积极结合客户需求推进相关布局,希望为公司带来积极的贡献。
金融界5月6日消息,有投资者在互动平台向博腾股份提问:董秘你好,公司有合成尼古丁原料的技术吗,谢谢。
公司回答表示:公司于 2014 年获得欧洲药品质量管理和医疗保健局(EDQM) 签发的尼古丁原料药 CEP 证书,用于药用尼古丁领域,后续又获得电子烟用烟碱牌照。公司将在技术能力、供应链能力和市场开发层面,积极结合客户需求推进相关布局,希望为公司带来积极的贡献。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.